Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Gross Sales	$ 5,173,878	$ 6,462,965	$ 15,365,953	$ 19,288,155
Allowances	0	(343,585)	(440,152)	(843,538)
Total Net Sales	5,173,878	6,119,380	14,925,801	18,444,617
Cost of sales	1,770,364	2,273,839	5,384,061	7,015,803
Gross Profit	3,403,514	3,845,541	9,541,740	11,428,814
Operating expenses	3,785,542	5,669,194	12,540,595	18,699,293
Loss from operations	(382,028)	(1,823,653)	(2,998,855)	(7,270,479)
Decrease of contingent liability	0	44,771	74,580	153,771
Decrease (increase) in fair value of convertible debt	854,506	0	(591,494)	0
Other income	0	9,725	0	59,269
Interest expense	(12,741)	(1,246)	(31,558)	(5,831)
Income (loss) before provision for income taxes	459,737	(1,770,404)	(3,547,327)	(7,063,270)
Net Income (loss)	459,737	(1,770,404)	(3,547,327)	(7,063,270)
Preferred dividends	1,000,500	1,000,501	3,001,501	3,001,503
Net Loss attributable to cbdMD, Inc. common shareholders	$ (540,763)	$ (2,770,904)	$ (6,548,828)	$ (10,064,773)
Net Loss per common share:
Basic loss per share (in dollars per share)	$ (0.15)	$ (1.16)	$ (1.84)	$ (4.26)
Diluted loss per share (in dollars per share)	$ (0.15)	$ (1.16)	$ (1.84)	$ (4.26)
Weighted average number of shares Basic and diluted: (in shares)	3,592,969	2,379,633	3,561,884	2,360,908